Spots Global Cancer Trial Database for posaconazole
Every month we try and update this database with for posaconazole cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Posaconazole Prophylaxis During ATG Treatment for hMDS/AA Patients | NCT03318159 | Aplastic Anemia Myelodysplastic... Fungal Infectio... | Posaconazole | 18 Years - 75 Years | Seoul National University Hospital | |
| Study of ABT-199 (GDC-0199) in Combination With Azacitidine or Decitabine (Chemo Combo) in Subjects With Acute Myelogenous Leukemia (AML) | NCT02203773 | Acute Myelogeno... Myelogenous Leu... Treatment Naive... | Posaconazole ABT-199 Decitabine Azacitidine | 60 Years - | AbbVie | |
| Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115) | NCT00686543 | Fungal Infectio... Acute Myelogeno... Neutropenia | Posaconazole | 18 Years - | Merck Sharp & Dohme LLC | |
| Posaconazole Prophylaxis During ATG Treatment for hMDS/AA Patients | NCT03318159 | Aplastic Anemia Myelodysplastic... Fungal Infectio... | Posaconazole | 18 Years - 75 Years | Seoul National University Hospital | |
| A Study of the Drug-Drug Interaction of RO5503781 and Posaconazole, the Relative Bioavailability of New Formulations of RO5503781 and the Food-Effect on the Pharmacokinetics of RO5503781 in Patients With Solid Tumors | NCT01901172 | Neoplasms | RO5503781 RO5503781 RO5503781 RO5503781 posaconazole | 18 Years - | Hoffmann-La Roche | |
| A Study of the Drug-Drug Interaction of RO5503781 and Posaconazole, the Relative Bioavailability of New Formulations of RO5503781 and the Food-Effect on the Pharmacokinetics of RO5503781 in Patients With Solid Tumors | NCT01901172 | Neoplasms | RO5503781 RO5503781 RO5503781 RO5503781 posaconazole | 18 Years - | Hoffmann-La Roche | |
| King's Invasive Aspergillosis Study II | NCT02875743 | Aplastic Anemia Leukemia, Myelo... Myelodysplastic... Bone Marrow Tra... | Posaconazole | 18 Years - | King's College Hospital NHS Trust | |
| Pharmacokinetics of Posaconazole Prophylaxis in Acute Leukemia | NCT00936117 | Leukemia Fungal Infectio... | Posaconazole | 18 Years - | M.D. Anderson Cancer Center | |
| DS-1594b With or Without Azacitidine, Venetoclax, or Mini-HCVD for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia | NCT04752163 | Hematopoietic a... Recurrent Acute... Recurrent Acute... Recurrent Chron... Recurrent Myelo... Refractory Acut... Refractory Acut... Refractory Chro... Refractory Myel... | DS-1594b Azacitidine Cyclophosphamid... Cytarabine Dexamethasone Filgrastim Leucovorin Mesna Methotrexate Posaconazole Prednisone Rituximab Venetoclax Vincristine Voriconazole | 18 Years - | M.D. Anderson Cancer Center | |
| Oral Posaconazole Three Times Per Day vs Weekly High Dose Amphotericin B Lipid Complex (ABLC) | NCT00750737 | Invasive Fungal... Hematologic Mal... | Posaconazole ABLC | 18 Years - | M.D. Anderson Cancer Center | |
| Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115) | NCT00686543 | Fungal Infectio... Acute Myelogeno... Neutropenia | Posaconazole | 18 Years - | Merck Sharp & Dohme LLC | |
| Neuro-pharmacological Properties of Repurposed Posaconazole in Glioblastoma: A Phase 0 Clinical Trial | NCT04825275 | Glioblastoma Glioblastoma Mu... Glioblastoma Mu... Glioblastoma Mu... | Posaconazole Pi... | 18 Years - | Milton S. Hershey Medical Center | |
| Breakthrough Invasive Mold Infections Under Posaconazole Prophylaxis (BIMI) | NCT04720144 | Invasive Mold I... Breakthrough In... Hematologic Mal... Hematologic Dis... | 18 Years - | Centre Hospitalier Universitaire Vaudois | ||
| King's Invasive Aspergillosis Study II | NCT02875743 | Aplastic Anemia Leukemia, Myelo... Myelodysplastic... Bone Marrow Tra... | Posaconazole | 18 Years - | King's College Hospital NHS Trust | |
| Breakthrough Invasive Mold Infections Under Posaconazole Prophylaxis (BIMI) | NCT04720144 | Invasive Mold I... Breakthrough In... Hematologic Mal... Hematologic Dis... | 18 Years - | Centre Hospitalier Universitaire Vaudois | ||
| PTX3-targeted Antifungal Prophylaxis | NCT03828773 | Candidiasis Fungal Infectio... Acute Myeloid L... Genetic Predisp... Aspergillosis | Posaconazole Fluconazole | 18 Years - | Centre Hospitalier Universitaire Vaudois | |
| Pharmacokinetics Variability of Posaconazole (PCZ) and Its Glucuronide Metabolite During Induction and Consolidation Treatments in Patients With Acute Myeloid Leukemia (AML): a Covariate Analysis With the Tablets Formulation and Evaluation of the Potential Risk of Hepatotoxicity | NCT03796533 | Leukemia, Myelo... | Posaconazole | 18 Years - | Hospices Civils de Lyon | |
| Neuro-pharmacological Properties of Repurposed Posaconazole in Glioblastoma: A Phase 0 Clinical Trial | NCT04825275 | Glioblastoma Glioblastoma Mu... Glioblastoma Mu... Glioblastoma Mu... | Posaconazole Pi... | 18 Years - | Milton S. Hershey Medical Center | |
| Pharmacokinetics of Posaconazole (Noxafil®) as Prophylaxis for Invasive Fungal Infections | NCT02805946 | Allogeneic Stem... Acute Graft Ver... Acute Myeloid L... Myelo Dysplasti... | posaconazole | 18 Years - | Radboud University Medical Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
